Dr. Thomas A. D'Amico, MD

Dr. D'Amico practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. D'Amico's NPI, 1023171899, was assigned on December 19, 2006. Dr. D'Amico graduated from Vagelos College of Physicians and Surgeons in 1987. Dr. D'Amico holds North Carolina license 36336.

Dr. D'Amico's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. D'Amico's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. D'Amico to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. D'Amico practices, 2 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. D'Amico's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. D'Amico is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. D'Amico's licenses on file in 2 states: North Carolina and Florida.

Dmand AI lists esophagus, stomach, or upper small intestine surgery and lung resection among the conditions Dr. D'Amico treats.

CMS data shows 163 Medicare services from Dr. D'Amico across 6 procedure codes in 2024, for 98 Medicare patients. Medicare paid $27,152 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. D'Amico in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. D'Amico's median patient age at 72, with 48% women.

In 2016, Dr. D'Amico wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $315 in total drug cost.

Dr. D'Amico accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 273 papers to Dr. D'Amico, published from 2006 to 2021. 2014 was the busiest year, with 18. The most frequent topics are Lung Neoplasms, Pneumonectomy and Carcinoma, Non-Small-Cell Lung. Dr. D'Amico has published most often in Ann Thorac Surg. Dr. D'Amico's most frequent co-authors are Mark Francis Berry, MD, Mark William Onaitis, MD and Matthew Galen Hartwig, MD.

Dmand AI links Dr. D'Amico to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 250 general payments to Dr. D'Amico from 15 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 48% of the total. Scanlan International Inc paid the most, $88,223.

Dmand AI lists 3 awards for Dr. D'Amico, most recently CMS Stage 1 EHR in 2013.

Dr. D'Amico graduated from Vagelos College of Physicians and Surgeons in 1987. Dr. D'Amico is a member of AATS, ACS and STS.

Dr. D'Amico is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.